Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cyclin-dependent Kinase 4 (CDK4)
96%
Overgrowth
80%
Replication Stress
73%
Oncogenic Signaling
66%
G1 Cell Cycle Arrest
66%
Cancer Cells
66%
CDK4/6 Inhibition
63%
Senescence
41%
Cell Growth
41%
DNA Damage
37%
Tumor Cells
36%
Osmotic Stress
33%
Tumor Subtype
33%
Cell Cycle Exit
28%
G1 Arrest
26%
Mitosis
26%
DNA Replication
22%
Breast Cancer
22%
Sigma Phase
21%
In Cancer
21%
Long-lasting Effect
17%
Tumor Growth
17%
Genotoxic Damage
15%
Mammalian Target of Rapamycin (mTOR)
15%
Healthy Tissue
15%
Excessive Growth
15%
Transformed Cells
15%
HER2 Breast Cancer
13%
Origin Licensing
11%
G1 Phase
11%
Replisome
11%
Proliferative Potential
11%
Clinical Trials
11%
Cytostatic
11%
Genotoxic Stress
11%
Combination Therapy
11%
Effective Combination
11%
Tumor-specific
8%
Cell Cycle Arrest
8%
Anticancer Drugs
8%
Synthetic Lethal
8%
Specific Toxicity
8%
Cell Size
6%
Hypertrophy
6%
Cell Fate
6%
Size Dependence
6%
Tumor Microenvironment
6%
Tumor Proliferation
6%
Cancer Research
6%
Tumor Immunity
6%
Biochemistry, Genetics and Molecular Biology
G1/S Transition
75%
Cancer Cell
66%
Carcinogenesis
66%
Cell Cycle
60%
Cell Growth
40%
DNA Damage
30%
Tumor Progression
21%
Mitosis
21%
Cell Cycle Exit
20%
DNA Synthesis
16%
S Phase
13%
Mammalian Target of Rapamycin
13%
P53
8%
Replisome
8%
G1 Phase
8%
Clinical Trial
8%
Chromosome
8%
Cell Cycle Arrest
6%
Cell Cycle Checkpoint
6%
Tumor Immunity
6%
Anticancer
6%
Immunology and Microbiology
Cell Cycle
100%
Replication
66%
G1 Phase Cell Cycle Checkpoint
41%
DNA Damage
33%
Cancer Cell
33%
Tumor Cell
33%
Mitosis
25%
Cell Growth
16%
Non-Transformed Cell
16%
Cell Cycle Arrest
16%
DNA Synthesis
16%
Cell Cycle Checkpoint
16%
P53
15%
Replisome
8%
Cell Cycle G1 Phase
8%
Chromosome
8%
Cell Fate
6%
Osmotic Stress
6%
Cell Size
6%
